CSW Industrials (CSW) CEO sells 1,500 shares under 10b5-1 plan
Rhea-AI Filing Summary
CSW Industrials, Inc. Chairman, President & CEO Joseph B. Armes sold 1,500 shares of common stock in an open‑market transaction on April 15, 2026 at a weighted average price of $286.7671 per share. The sale was executed under a pre‑arranged Rule 10b5‑1 trading plan established on August 12, 2025, indicating it was scheduled in advance.
Following the sale, he directly holds 84,494 common shares and indirectly holds 3,219 shares through an ESOP. He also has performance rights tied to 8,004, 8,236 and 9,186 underlying shares and 19,685 restricted stock units, each representing a contingent right to receive one share at vesting, with payouts based on relative total shareholder return or successful CEO succession milestones.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,500 | $286.7671 | $430K |
| holding | Performance Rights | -- | -- | -- |
| holding | Performance Rights | -- | -- | -- |
| holding | Performance Rights | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (6)
- F1. The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 12, 2025.
- F2. The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $283.695 to $302.93, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F3. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2025, and ending on March 31, 2028, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- F4. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024, and ending on March 31, 2027, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- F5. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200%, during a performance cycle beginning April 1, 2021 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- F6. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at vesting. 40% of the restricted stock units vest no earlier than April 26, 2025 upon the successful recruitment and hiring of a successor Chief Executive Officer; the remaining 60% vest upon the successful first employment anniversary of a successor Chief Executive Officer.
Key Figures
Key Terms
Rule 10b5-1 trading plan financial
performance rights financial
restricted stock unit financial
Russell 2000 Index financial
Employee Stock Ownership Plan financial
AI-generated analysis. How Rhea-AI works. Not financial advice.